A new trading day began on Tuesday, with Alx Oncology Holdings Inc (NASDAQ: ALXO) stock price up 12.68% from the previous day of trading, before settling in for the closing price of $0.59. ALXO’s price has ranged from $0.40 to $2.89 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -32.29% over the last five years. Meanwhile, its annual earnings per share averaged 37.86%. With a float of $36.79 million, this company’s outstanding shares have now reached $53.38 million.
The firm has a total of 80 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Alx Oncology Holdings Inc (ALXO) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Alx Oncology Holdings Inc is 31.17%, while institutional ownership is 45.85%. The most recent insider transaction that took place on Jul 07 ’25, was worth 905. In this transaction SVP, FINANCE AND CAO of this company sold 2,011 shares at a rate of $0.45, taking the stock ownership to the 86,809 shares. Before that another transaction happened on Jun 30 ’25, when Company’s SVP, FINANCE AND CAO sold 1,532 for $0.43, making the entire transaction worth $659. This insider now owns 88,820 shares in total.
Alx Oncology Holdings Inc (ALXO) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 37.86% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.05% during the next five years compared to -32.29% drop over the previous five years of trading.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Trading Performance Indicators
Here are Alx Oncology Holdings Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.47, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.19 in one year’s time.
Technical Analysis of Alx Oncology Holdings Inc (ALXO)
Analysing the last 5-days average volume posted by the [Alx Oncology Holdings Inc, ALXO], we can find that recorded value of 0.47 million was lower than the volume posted last year of 0.75 million. As of the previous 9 days, the stock’s Stochastic %D was 68.21%.
During the past 100 days, Alx Oncology Holdings Inc’s (ALXO) raw stochastic average was set at 43.87%, which indicates a significant decrease from 98.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0546 in the past 14 days, which was higher than the 0.0510 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5044, while its 200-day Moving Average is $0.9822.
